![logo](/logos/NVTA.webp)
Invitae Corporation
NYSE:NVTA
0.02 (USD) • At close February 14, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Invitae Corporation |
Symbool | NVTA |
Munteenheid | USD |
Prijs | 0.019 |
Beurswaarde | 5,443,367 |
Dividendpercentage | 0% |
52-weken bereik | 0.015 - 2.34 |
Industrie | Diagnostics & Research |
Sector | Healthcare |
CEO | Mr. Kenneth D. Knight |
Website | https://www.invitae.com |
An error occurred while fetching data.
Over Invitae Corporation
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases; digital health solutions; and health
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)